222 related articles for article (PubMed ID: 20923321)
21. Formulation, evaluation and pharmacokinetics of colon targeted pulsatile system of flurbiprofen.
Veerareddy PR; Vemula SK
J Drug Target; 2012 Sep; 20(8):703-14. PubMed ID: 22845842
[TBL] [Abstract][Full Text] [Related]
22. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
Liu F; Moreno P; Basit AW
Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
[TBL] [Abstract][Full Text] [Related]
23. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
24. Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD).
Leopold CS; Eikeler D
J Drug Target; 1998; 6(2):85-94. PubMed ID: 9886233
[TBL] [Abstract][Full Text] [Related]
25. Modulating pH-independent release from coated pellets: effect of coating composition on solubilization processes and drug release.
Ensslin S; Moll KP; Metz H; Otz M; Mäder K
Eur J Pharm Biopharm; 2009 May; 72(1):111-8. PubMed ID: 19084061
[TBL] [Abstract][Full Text] [Related]
26. Design and evaluation of floating multi-layer coated tablets based on gas formation.
Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
[TBL] [Abstract][Full Text] [Related]
27. Pharmaceutical design of a novel colon-targeted delivery system using two-layer-coated tablets of three different pharmaceutical formulations, supported by clinical evidence in humans.
Goto T; Tanida N; Yoshinaga T; Sato S; Ball DJ; Wilding IR; Kobayashi E; Fujimura A
J Control Release; 2004 May; 97(1):31-42. PubMed ID: 15147802
[TBL] [Abstract][Full Text] [Related]
28. ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability.
Maurer JM; Schellekens RC; van Rieke HM; Stellaard F; Wutzke KD; Buurman DJ; Dijkstra G; Woerdenbag HJ; Frijlink HW; Kosterink JG
J Control Release; 2013 Dec; 172(3):618-24. PubMed ID: 24096020
[TBL] [Abstract][Full Text] [Related]
29. Design of experiment approach for formulating multi-unit colon-targeted drug delivery system: in vitro and in vivo studies.
Shah N; Sharma OP; Mehta T; Amin A
Drug Dev Ind Pharm; 2016; 42(5):825-35. PubMed ID: 27019195
[TBL] [Abstract][Full Text] [Related]
30. Design of a potential colonic drug delivery system of mesalamine.
Gohel MC; Parikh RK; Nagori SA; Dabhi MR
Pharm Dev Technol; 2008; 13(5):447-56. PubMed ID: 18798122
[TBL] [Abstract][Full Text] [Related]
31. Development of pulsatile systems for targeted drug delivery of celecoxib for prophylaxis of colorectal cancer.
Sinha VR; Bhinge JR; Kumria R; Kumar M
Drug Deliv; 2006; 13(3):221-5. PubMed ID: 16556575
[TBL] [Abstract][Full Text] [Related]
32. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
Patel MM; Amin AF
Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
[TBL] [Abstract][Full Text] [Related]
33. Development of multiple-unit colon-targeted drug delivery system by using alginate: in vitro and in vivo evaluation.
Lai H; Zhu F; Yuan W; He N; Zhang Z; Zhang X; He Q
Drug Dev Ind Pharm; 2011 Nov; 37(11):1347-56. PubMed ID: 21524152
[TBL] [Abstract][Full Text] [Related]
34. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
[TBL] [Abstract][Full Text] [Related]
35. Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems.
Fadda HM; Merchant HA; Arafat BT; Basit AW
Int J Pharm; 2009 Dec; 382(1-2):56-60. PubMed ID: 19666093
[TBL] [Abstract][Full Text] [Related]
36. Development of a multiple-unit tablet containing enteric-coated pellets.
Dreu R; Ilić I; Srčič S
Pharm Dev Technol; 2011 Apr; 16(2):118-26. PubMed ID: 20088675
[TBL] [Abstract][Full Text] [Related]
37. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
38. A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine.
Liu F; Lizio R; Meier C; Petereit HU; Blakey P; Basit AW
J Control Release; 2009 Jan; 133(2):119-24. PubMed ID: 18930772
[TBL] [Abstract][Full Text] [Related]
39. Design of tablets for the delayed and complete release of poorly water-soluble weak base drugs using SBE7M-β-CD as a solubilizing agent.
Rao VM; Zannou EA; Stella VJ
J Pharm Sci; 2011 Apr; 100(4):1576-87. PubMed ID: 24081477
[TBL] [Abstract][Full Text] [Related]
40. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations.
Khan MZ; Stedul HP; Kurjaković N
Drug Dev Ind Pharm; 2000 May; 26(5):549-54. PubMed ID: 10789067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
